Tenders/Request For Proposal (RFP) for Pharmacological testing of novel stimulants, and synthetic cannabinoids.

Request For Proposal (RFP) for Pharmacological testing of novel stimulants, and synthetic cannabinoids.

Department of Health (HC)

Published: Oct 27, 2026

Updated: Oct 28, 2026

Source: CanadaBuys - Government of Canada

About This Opportunity

This is a consulting contract in the health and medical services and Research sectors, with a focus on Pharmaceuticals. Located in Canada, North America, this opportunity is open to firms and consortiums.

Published through CanadaBuys - Government of Canada, a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for consulting in the health and medical services sector. Consulting assignments are typically evaluated with a strong emphasis on the technical proposal, including the methodology and qualifications of key experts. Shortlisted firms may be invited to submit financial proposals in a second stage. Interested parties should review the full documentation on the original source before submitting their proposal.

Description

Amended Request For Proposal (RFP) for Pharmacological testing of stimulants, and synthetic cannabinoids. Novel psychoactive substances (NPS) in the illegal drug supply pose risks to Canadians. However, little is known about their pharmacological activity. More potent drugs increase the risk of overdose risks. Evidence on the pharmacological activity of these substances is essential to support scientific regulatory activities and risk assessments. The illegal drug supply is continuously evolving, with new substances continually being detected. There is a need for further information on their harms to Canadians. This procurement activity will allow for the evaluation of the in vitro pharmacological activity of two categories of emerging drugs: synthetic cannabinoids, and stimulants. The data generated from this contract will inform future assessment activities and allow the OLRA to make more informed regulatory science decisions. For both streams, they require the pharmacological testing of different classes of substances, and require acquisition of reference standards and control samples, getting licenses for controlled substances, conducting experiments (including doing statistical analysis), and finally drafting and finalizing reports. Canada is seeking offers from Offerors to provide Pharmacological Testing for Stimulants, and Synthetic Cannabinoids in two (2) separate streams to Health Canada. Stream 2 – In vitro pharmacological testing of novel synthetic cannabinoids and Stream 3 – In vitro pharmacological testing of stimulant compounds. Each stream will be evaluated separately, and bidders are to provide their submissions for one (1) stream or two (2) streams. Up to two (2) contracts may be awarded under this amended request for proposal.. UNSPSC: *Drugs and Pharmaceutical Products (*51000000). Method: Competitive - Open bidding. Selection: Highest Combined Rating of Technical Merit and Price. Trade Agreements: *North American Free Trade Agreement (NAFTA) *Canada-Korea Free Trade Agreement (CKFTA). Regions: *Canada

Data provenance

This notice is sourced from CanadaBuys - Government of Canada and was originally published on October 27, 2026. Last refreshed today. BidsFactory mirrors official procurement notices and links back to the source for full legal text.

About Department of Health (HC)

Department of Health (HC) has issued 25 procurement notices on BidsFactory, including 1 currently open and 5 awarded contracts. Activity concentrates in Health & Medical, Research & Innovation, and Information & Communication Technology. All notices are published for Canada. Notices are distributed via CanadaBuys - Government of Canada. Most recent publication: October 27, 2026.

Frequently asked questions about this tender

How can I submit a bid?

Visit CanadaBuys - Government of Canada to access the full notice, required documents, and submission instructions provided by the contracting authority.

Who is the contracting authority?

This notice was issued by Department of Health (HC) in Canada. The authority is responsible for evaluating bids, awarding the contract, and managing performance.

What type of contract is this?

This is a Consulting contract in the Health & Medical sector. The classification helps bidders match the opportunity to their qualifications and registered scope of supply.

Where will the contract be performed?

The contract is for delivery in Canada. Foreign bidders should review local registration, taxation, and any in-country presence requirements before submitting.